J A Cook|C Steel|E A Ottesen - JoVE Visualize

Showing results (641-650 of 679) with videos related to

Pageof 68

Sort By:

International Journal of Radiation Oncology, Biology, Physics|November 15, 1994

Protection against SR 4233 (Tirapazamine) aerobic cytotoxicity by the metal chelators desferrioxamine and tironL L Herscher, M C Krishna, J A Cook, et al.

The Bone & Joint Journal|January 3, 2019

Cost-effectiveness analysis of a placebo-controlled randomized trial evaluating the effectiveness of arthroscopic subacromial decompression in patients with subacromial shoulder painI Rombach, N Merritt, B A Shirkey, et al.

BJS Open|October 5, 2020

Recruitment and retention of participants in UK surgical trials: survey of key issues reported by trial staffJ C Crocker, N Farrar, J A Cook, et al.

The New England Journal of Medicine|December 22, 1983

Morbidity in schistosomiasis japonica in relation to intensity of infection. A study of two rural brigades in Anhui Province, ChinaK S Warren, D L Su, Z Y Xu, et al.

Molecules (Basel, Switzerland)|December 23, 2022

Pro-Inflammatory Interactions of Dolutegravir with Human Neutrophils in an In Vitro StudyAnnette J Theron, Ronald Anderson, Morris Madzime, et al.

Cancer Research|February 1, 1992

Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridineJ A Cook, J Glass, R Lebovics, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996

Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitroJ S Berman, R L Blumenthal, H Kornfeld, et al.

Biochemistry. Biokhimiia|August 29, 1998

The role of nitric oxide chemistry in cancer treatmentD A Wink, Y Vodovotz, J A Cook, et al.

Frontiers in Immunology|June 9, 2022

Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint MoleculesBernardo L Rapoport, Helen C Steel, Nomsa Hlatshwayo, et al.

Frontiers in Oncology|April 17, 2023

Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3Bernardo L Rapoport, Helen C Steel, Carol A Benn, et al.

Pageof 68

Showing results (641-650 of 679) with videos related to

Sort By:

Pageof 68

International Journal of Radiation Oncology, Biology, Physics|November 15, 1994

Protection against SR 4233 (Tirapazamine) aerobic cytotoxicity by the metal chelators desferrioxamine and tironL L Herscher, M C Krishna, J A Cook, et al.

The Bone & Joint Journal|January 3, 2019

Cost-effectiveness analysis of a placebo-controlled randomized trial evaluating the effectiveness of arthroscopic subacromial decompression in patients with subacromial shoulder painI Rombach, N Merritt, B A Shirkey, et al.

BJS Open|October 5, 2020

Recruitment and retention of participants in UK surgical trials: survey of key issues reported by trial staffJ C Crocker, N Farrar, J A Cook, et al.

The New England Journal of Medicine|December 22, 1983

Morbidity in schistosomiasis japonica in relation to intensity of infection. A study of two rural brigades in Anhui Province, ChinaK S Warren, D L Su, Z Y Xu, et al.

Molecules (Basel, Switzerland)|December 23, 2022

Pro-Inflammatory Interactions of Dolutegravir with Human Neutrophils in an In Vitro StudyAnnette J Theron, Ronald Anderson, Morris Madzime, et al.

Cancer Research|February 1, 1992

Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridineJ A Cook, J Glass, R Lebovics, et al.

Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1996

Chemotactic activity of mycobacterial lipoarabinomannans for human blood T lymphocytes in vitroJ S Berman, R L Blumenthal, H Kornfeld, et al.

Biochemistry. Biokhimiia|August 29, 1998

The role of nitric oxide chemistry in cancer treatmentD A Wink, Y Vodovotz, J A Cook, et al.

Frontiers in Immunology|June 9, 2022

Systemic Immune Dysregulation in Early Breast Cancer Is Associated With Decreased Plasma Levels of Both Soluble Co-Inhibitory and Co-Stimulatory Immune Checkpoint MoleculesBernardo L Rapoport, Helen C Steel, Nomsa Hlatshwayo, et al.

Frontiers in Oncology|April 17, 2023

Dysregulation of systemic soluble immune checkpoints in early breast cancer is attenuated following administration of neoadjuvant chemotherapy and is associated with recovery of CD27, CD28, CD40, CD80, ICOS and GITR and substantially increased levels of PD-L1, LAG-3 and TIM-3Bernardo L Rapoport, Helen C Steel, Carol A Benn, et al.

Pageof 68